(141C)tanzisertib,
4-(9-(tetrahydrofuran-3-yl)-8-(2,4,6-trifluorophenylamino)-9H-purin-2-ylamino)cyclohexanol,
tanzisertib,
TANZISERTIB,
CC-930,
899805-25-5,
CC 930,
UNII-M5O06306UO,
CHEMBL1950289,
CC930,
M5O06306UO,
Trans-4-({9-[(3s)-Tetrahydrofuran-3-Yl]-8-[(2,4,6-Trifluorophenyl)amino]-9h-Purin-2-Yl}amino)cyclohexanol,
Tanzisertib [USAN:INN],
3tti,
trans-4-((9-((3S)-Tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexanol,
Tanzisertib (USAN),
CC-930(Tanzisertib),
GTPL9836,
SCHEMBL2133055,
SCHEMBL2133061,
SCHEMBL4760419,
SCHEMBL8082102,
CHEMBL1950305,
SCHEMBL10179476,
SCHEMBL15589918,
JNK-930,
BCP16541,
BDBM50364378,
AKOS030525451,
ZINC100285204,
ZINC102930548,
compound 1 [PMID: 22244937],
CS-1544,
DB11798,
NCGC00378972-01,
HY-15495,
D10168,
W-6005,
(1S,4r)-4-((9-((S)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexanol,
Cyclohexanol, 4-((9-((3S)-tetrahydro-3-furanyl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)-, trans-,
KBI,
trans-4-(9-((S)-tetrahydrofuran-3-yl)-8-(2,4,6-trifluorophenylamino)-9H-purin-2-ylamino)cyclohexanol,
Tanzisertib [USAN],
D0X4MN,
C21-H23-F3-N6-O2,
CID11597537,
A3288,
A13564,
4-[[9-[(3S)-oxolan-3-yl]-8-[(2,4,6-trifluorophenyl)amino]purin-2-yl]amino]cyclohexan-1-ol,
4-[[9-[(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9Hpurin-2-yl]amino]-trans-cyclohexanol,
Cyclohexanol, 4-((9-((3S)-tetrahydro-3-furanyl)-8-((2,4,6-trifluorophenyl)amino)-9H- purin-2-yl)amino)-, trans-,
Cyclohexanol, 4-[[9-[(3S)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9H- purin-2-yl]amino]-, trans-,
Trans-4-((9-((3S)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2- yl)amino)cyclohexanol,
trans-4-({9-[(3S)-tetrahydrofuran-3-yl]-8-[(2,4,6-trifluorophenyl)amino]-9H-purin-2- yl}amino)cyclohexanol,